HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diffusion kurtosis imaging and dynamic contrast-enhanced MRI for the differentiation of parotid gland tumors.

AbstractOBJECTIVE:
To assess the usefulness of combined diffusion kurtosis imaging (DKI) and dynamic contrast-enhanced MRI (DCE-MRI) in the differentiation of parotid gland tumors.
METHODS:
Seventy patients with 80 parotid gland tumors who underwent DKI and DCE-MRI were retrospectively enrolled and divided into four groups: pleomorphic adenomas (PAs), Warthin tumors (WTs), other benign tumors (OBTs), and malignant tumors (MTs). DCE-MRI and DKI quantitative parameters were measured. The Kruskal-Wallis H test and post hoc test with Bonferroni correction and ROC curve were used for statistical analysis.
RESULTS:
WTs demonstrated the highest Kep value (median 1.89, interquartile range [1.46-2.31] min-1) but lowest Ve value (0.20, [0.15-0.25]) compared with PAs (Kep, 0.34 [0.21-0.55] min-1; Ve, 0.36 [0.24-0.43]), OBTs (Kep, 1.22 [0.27-1.67] min-1; Ve, 0.28 [0.25-0.41]), and MTs (Kep, 0.71 [0.50-1.23] min-1; Ve, 0.35 [0.26-0.45]) (all p < .05). MTs had the lower D value (1.10, [0.88-1.29] × 10-3 mm2/s) compared with PAs (1.81, [1.60-2.20] × 10-3 mm2/s) and OBTs (1.57, [1.32-1.89] × 10-3 mm2/s) (both p < .05). PAs had the lower Ktrans value (0.12, [0.07-0.18] min-1) compared with OBTs (0.28, [0.11-0.50] min-1) (p < .05). The cutoff values of combined Kep and Ve, D, and Ktrans to distinguish WTs, MTs, and PAs sequentially were 1.06 min-1, 0.28, 1.46 × 10-3 mm2/s, and 0.21 min-1, respectively (accuracy, 89% [71/80], 91% [73/80], 78% [62/80], respectively).
CONCLUSION:
The combined use of DKI and DCE-MRI may help differentiate parotid gland tumors.
KEY POINTS:
• The combined use of DKI and DCE-MRI could facilitate the understanding of the pathophysiological characteristics of parotid gland tumors. • A stepwise diagnostic diagram based on the combined use of DCE-MRI parameters and the diffusion coefficient is helpful for accurate preoperative diagnosis in parotid gland tumors and may further facilitate the clinical management of patients.
AuthorsNan Huang, Yu Chen, Dejun She, Zhen Xing, Tanhui Chen, Dairong Cao
JournalEuropean radiology (Eur Radiol) Vol. 32 Issue 4 Pg. 2748-2759 (Apr 2022) ISSN: 1432-1084 [Electronic] Germany
PMID34642805 (Publication Type: Journal Article)
Copyright© 2021. The Author(s).
Chemical References
  • Contrast Media
Topics
  • Contrast Media (pharmacology)
  • Diagnosis, Differential
  • Diffusion Magnetic Resonance Imaging
  • Humans
  • Magnetic Resonance Imaging (methods)
  • Parotid Gland (diagnostic imaging)
  • Parotid Neoplasms (diagnostic imaging)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: